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Abstract.  SNAP-25  is known as a neuron specific 
molecule involved  in the fusion of small synaptic vesi- 
cles with the presynaptic plasma membrane. By im- 
munolocalization and Western blot analysis, it is now 
shown that SNAP-25  is also expressed in pancreatic 
endocrine cells.  Botulinum neurotoxins (BoNT)  A and 
E were used to study the role of SNAP-25  in insulin 
secretion. These neurotoxins inhibit transmitter release 
by cleaving SNAP-25  in neurons. 
Cells from a pancreatic B cell line (HIT) and pri- 
mary rat islet cells were permeabilized with strepto- 
lysin-O to allow toxin entry. SNAP-25  was cleaved  by 
BoNT/A and BoNT/E, resulting in a molecular mass 
shift of ~ol and 3 kD,  respectively.  Cleavage was 
accompanied by an inhibition of Ca÷÷-stimulated insu- 
lin release in both cell types. In HIT cells, a concen- 
tration of 30-40 nM BoNT/E gave maximal inhibition 
of stimulated insulin secretion of '~60%, coinciding 
with essentially complete cleavage of SNAP-25.  Half 
maximal effects in terms of cleavage and inhibition of 
insulin release were obtained at a concentration of 
5-10 nM. The A type toxin showed maximal and half- 
maximal effects at concentrations of 4 and 2 nM, re- 
spectively.  In conclusion, the results suggest a role for 
SNAP-25  in fusion of dense core secretory granules 
with the plasma membrane in an endocrine cell type- 
the pancreatic B cell. 
I 
N pancreatic  B cells, proinsulin  is sorted in the trans- 
Golgi network for delivery to secretory granules where 
it is processed to insulin (23, 40). Insulin is packed and 
stored  in large  dense  core granules  (LDCG) ~ and is  re- 
leased when exocytosis is stimulated by secretagogues such 
as glucose (23). Current understanding of B cell stimulus- 
secretion coupling suggests that nutrient stimuli cause de- 
polarization of the cell membrane, which leads to an influx 
of Ca  ++ triggering the fusion of granules  with the plasma 
membrane  (48). Although  sensitivity to glucose  is a pe- 
culiarity  of the pancreatic  B cell,  the other steps leading 
from the trans-Golgi network to LDCGs and the fusion of 
granules  with  the  plasma  membrane  are,  most probably, 
Please address all correspondence to Dr. Karin Sadoul,  Laboratoires de 
Recherche Louis Jeantet,  Centre Medical Universitaire,  1,  rue  Michel- 
Servet, CH-1211 Geneva 4, Switzerland. Tel.: 41 22 7025537.  Fax.: 41 22 
3473334. 
1. Abbreviations used in this paper: BoNT, botulinum neurotoxin; LDCG, 
large dense core granule; LDCV, large dense core vesicle; NSE N-ethyl- 
maleimid-sensitive factor; SLMV, synaptic-like microvesicle; SNAP, solu- 
ble NSF attachment protein; SNAP-25,  synaptosomal-associated protein of 
25 kD;  SSV, small synaptic vesicle. 
common  to  all  cells  possessing  the  regulated  secretory 
pathway. 
The  molecular  mechanism  for  docking  and  fusion  of 
LDCGs in endocrine cells has not so far been studied. Con- 
versely, recent data from S611ner et al.  have established a 
detailed model for docking and fusion of small synaptic vesi- 
cles (SSV) in neuronal cells (57, 58). Using cosedimentation 
and immunoprecipitation  techniques they could identify a 
20-S fusion complex. The complex is formed when a brain 
membrane  detergent extract is mixed with NSF (N-ethyl- 
maleimid-sensitive factor) and SNAPs (soluble NSF attach- 
ment proteins)  in the presence  of non-hydrolyzable ATP. 
Besides  NSF  and SNAPs  this  complex  contains  VAMP/ 
synaptobrevin,  syntaxin,  and SNAP-25  (the  name  is  co- 
incidental  and  stands  in  this  instance  for synaptosomal- 
associated protein of 25 kD). VAMP/synaptobrevin is an in- 
tegral membrane protein of the synaptic vesicles (8, 64) and 
syntaxin  is  an integral  membrane  protein  located  on the 
plasma membrane (9). SNAP-25 lacks a transmembrane do- 
main but is attached to the plasma membrane by palmitoyla- 
tion of cysteine residues in the central domain of the mole- 
cule (26, 42). Additional proof for the involvement  of  VAMP/ 
synaptobrevin, syntaxin, and SNAP-25 in the fusion process 
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and botulinum serotypes A-G (BoNT/A-BoNT/G) (35,  38). 
These potent neurotoxins are metallo endoproteases, which 
block transmitter release at the synapse by cleaving VAMP/ 
synaptobrevin, syntaxin, or SNAP-25 (i0,  13,  14,  52, 53, 
55,  56). 
So far it is not clear to what extent features of this model 
can be applied to regulated exocytosis of different kinds of 
vesicles,  including  LDCGs,  or whether it is restricted to 
neurotransmitter release from SSVs in nerve terminals. 
In the present study we show that SNAP-25, previously 
thought to be a neuron specific protein (42), is also expressed 
in pancreatic endocrine cells including insulin producing B 
ceils. As in neurons SNAP-25 is found in the detergent solu- 
ble fraction of a crude preparation of total cellular mem- 
branes.  In  neurons  and  neurosecretory cells  SNAP-25  is 
cleaved at a site 9 and 26 amino acid residues from the car- 
boxy terminus by BoNT/A and BoNT/E, respectively (10, 
55),  which results in inhibition of transmitter release. We 
therefore used these toxins as tools to investigate the role of 
SNAP-25 in insulin secretion. BoNT/A and BoNT/E were 
found to hydrolyze SNAP-25  in  a  B  cell line  (HIT) and 
in  primary  islet  cells  accompanied  by  diminished  Ca++- 
induced insulin release. 
Materials and Methods 
Primary Cells 
Primary pancreatic islet cells and pure islet B and non-B cells were ob- 
tained as described previously (50). In brief, pancreata from six rats were 
digested with collagenase in Ca  ++ containing Hanks buffer and islets of 
Langerhans were separated from exocrine tissue by discontinuous density 
gradient centrifugation (Histopaque  1077 from  Sigma Chem.  Co.,  St. 
Louis, MO). Islets were trypsinized to obtain a single cell suspension and 
cultured in RPMI,  10%  FCS, 50 #g/mi gentamycin on glass coverslips 
coated with bovine corneal endothelial cell matrix (Eldan-Tech Ltd., Jerusa- 
lem, Israel) for immunofluorescence or in bovine corneal endothelial cell 
matrix coated 96-well plates (Eldan-Tech  Ltd.) for tox{n treatment. 
For Western blot analysis islet B cells were sorted from non-B cells by 
size and FAD auto fluorescence using a fluorescence-activated cell sorter 
(50).  This method has been shown to yield one population consisting of 
95 % B cells and a second with 93 % non-B cells as shown by classical dou- 
ble immunofluorescence  techniques (50). Isolated cells were lysed immedi- 
ately in SDS-sample buffer for gel electrophoresis. To obtain exocrine cells 
the pellet obtained after Histopaque density gradient centrifugation, con- 
taining exocrine acini, was washed twice with PBS and trypsinized to obtain 
a single cell suspension. Exocrine cells were counted and lysed immediately 
in SDS-sample buffer for gel electrophoresis. 
Cell Lines 
ART-20 (pituitary certicotroph), FAO (hepatoma), and COS (kidney) cells 
were grown in DMEM, 10% FCS. RIN cells (46) were cultured in RPMI 
1640,  10%  FCS, 2.05 rnM ghitamine; HIT cells (23, 42) in RPMI 1640, 
10%  FCS, 2.05  mM glutamine, 32.5 #M glutathione, 0.1 #M seleneons 
acid and INS-I cells (4) in RPMI 1640,  10% FCS, 10 mM Hepes, 2.05 mM 
glutamine,  1 mM Na-pyruvate, 0.05 mM/3-mercaptoethanol. 
Fractionation of CeU Lysates 
HIT cells were resuspended in PBS, 0.01% EDTA, and counted. Cells were 
lysed on ice in hypotonic buffer (20 mM "Iris,  1 mM EDTA, I mM EGTA 
1 mM PMSF, pH 7.4) using a dounce homogenizer. After low speed cen- 
trifugation (2,500 rpm, 10 rain, 4°C, Heraeus Biofnge) to eliminate nuclei, 
the postnuclear supernatant was centrifuged at 30000 g, 30 rain, 4°C to 
obtain a  crude membrane pellet and cytosol. The membrane pellet was 
washed once in high salt buffer (20 mM Tris, 1 mM EDTA, 1 mM EGTA, 
1 mM PMSF, 1 M NaCI, pH 7.4) before sohibilization with a detergent con- 
taming buffer (20 mM Tris, 1 raM EDTA, 1 mM EGTA, 1 mM PMSF, 150 
mM NaC1,  1% Triton X-100, pH 7.4).  Solubilized membranes were cen- 
trifuged at 100,000 g, 1 h, 4°C to separate Triton soluble membrane compo- 
nents  from  insoluble  material.  The  remaining pellet  was  resuspended 
directly in SDS-sample buffer for gel electrophoreses. All volumes were 
kept constant starting with I0  6 cells/lO0 #l hypotonic buffer. 
Immunofluorescence 
Cryosections of adult rat pancreas were fixed for 10 rain at room tempera- 
ture in PBS, 4%  paraformaldehyde blocked for 15  rain with Dulbecco's 
phosphate buffered saline (DPBS), 5 % BSA and incubated for 1 h in DPBS, 
0.1% BSA, 0.3% Triton X-100, containing a polyclonal antibody (diluted 
1:200)  against a synthetic peptide of the 12 carboxy terminal amino acid 
residues of SNAP-25 prepared as described (42). Sections were washed and 
incubated with  an  FITC-labeled  secondary  antibody  (dilution  of  1:80, 
Sigma catalogue number F-0382) for 1 h. Finally sections were mounted 
with mounting medium (Vectashield, Vector Laboratories Inc.,  Burlin- 
game, CA) and viewed using an Axiophot fluorescence microscope. Control 
sections were incubated in parallel, omitting the first antibody. 
Primary islet cells obtained as described above were cultured for 5 d be- 
fore immunofluorescence  staining. Ceils were fixed for 10 rain at room tem- 
perature in PBS, 4% paraformaldehyde, permeabilized in acetone for 30 s 
at room temperature, blocked for 15 rain in DPBS, 5% BSA before incuba- 
tion with a monoclonal antibody against SNAP-25 (diluted 1:1,000, Stem- 
berger Monoclonals Incorporated, Baltimore, MD) for 1 h in DPBS,  1% 
BSA. Cells were washed twice in DPBS, incubated with an FITC-labeled 
secondary antibody (1:1,000,  Antibodies Inc. catalogue number 41-150), 
and then visualized with an Axiophot fluorescence microscope. Control 
cells were treated identically without addition of the first antibody. 
Streptolysin-O Permeabilization and BoNT Treatment 
HIT cells were grown in 96-well plates (1.5 ×  105 cells/200 #l/well) for 3 
or 4  d  before permeabilization.  Formeabilization was performed as de- 
scribed previously (22). In brief, cells were washed once with 100 #l Krebs 
buffer without Ca  ++, and then with 100 #l glutamate buffer (140 mM K +- 
glutamate, 5 mM NaC1,  7 mM MgSO4, 20 mM Hepes, 0.4 mM EGTA, 
pH 7) at 37°C. Cells were then permeabilized with 50 #l streptolysin-O (ac- 
tivated with a final concentration of 5 mM DTT for 5 win a 37°C) in gluta- 
mate buffer (1.5 U/ml) for 7 rain at 370C, followed by an incubation period 
of 10 rain at 370C with 50/d glutamate buffer, low Ca  ++ (glutamate buffer 
containing 2.5 mM Na2ATE  0.5 mM CaCl2, 10.2 mM EGTA, resulting in 
a  final concentration of 0.1  t~M  free Ca++).  For measuring insulin se- 
cretion,  cells were incubated in 50  #l  glutamate buffer containing 2.5 
mM Na2ATE  10.2 mM EGTA and various concentrations of Ca++ (0.5 
mM CaC12 =  0.1 #M free Ca++, 7 mM CaC12 =  1 #M free Ca  ++, 9.8 mM 
CaCI2  =  10 #M free Ca  ++, 10 mM CaCl2  =  40 #M free Ca  ++) for 7 rain 
at 37°C. The concentration of free Ca  ++ has been estimated using a Ca++ 
concentration curve established with a Ca  ++ electrode and the same buffer 
composition as in our assay system (47). Incubation medium was taken for 
radioimmuno assay to measure insulin concentrations (25) (human insulin 
standard and anti-insulin serum from Novo-Nordisk, Bagsvaerd, Denmark) 
and cells were lysed in SDS sample buffer for gel electrophoresis. 
BoNT treatment of primary cells was performed identically except that 
the washing step with glutamate buffer was omitted and a 10 × less concen- 
trated streptolysin-O solution was used. The radioimmuno assay for insulin 
from primary cells was performed using a  rat insulin standard (Novo- 
Nordisk). 
BoNTs were obtained as described (54) and activated with a final concen- 
tration of 10 mM DTT at 37°C for 30 rain before use. Toxins were included 
during the permeabilization and preincubation periods. 
Western Blot Analysis 
SDS gel electrophoresis was performed under reducing conditions using 
10% polyacrylamide gels according to Laemmli et al. (27). Loading quanti- 
ties were as mentioned in figure legends or one fifth of a well from 96-well 
plates for toxin-treated cells. Transfer of proteins to nitrocellulose was per- 
formed as described (63). The nitrocellulose membranes were then blocked 
for 1 h at room temperature in TBS, 5 % dry milk (BioRad Labs., Hercules, 
CA) before incubation with the first antibody in TBS, 5% dry milk, 0.1% 
Tween-20  overnight at  4°C.  The  polyclonal  and  monoclonal antibody 
against SNAP-25 as well as the polyclonal antibody against actin (generous 
gift from Dr. Gabbiani, Geneva, Switzerland) and the monoclonal antibody 
against the heat shock protein HSP 70 (StressG-en, Victoria, B.C., Canada, 
catalogue number SPA-820) were diluted 1:1,000. The primary antibody was 
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combined  with the ECL detection  procedure from Amersham  International 
(Amersham, Bucks, UK) or with an alkaline  phosphatase-coupled  second- 
ary antibody  and a color substrate (66 #1 nitro-blue  tetrazolium,  50 mg/ml 
70% dimethylformamide  and 33 #1 5-bromo-4-chloro-3-indolylphosphate, 
50 mg/ml  dimethylformamide  in 10 ml 10 mM Tris, 100 mM NaCI, 5 mM 
MgCI2, pH 9.5). 
Results 
Expression of  SNAP-25 in the Islet of  Langerhans 
SNAP-25 expression was studied by immunofluorescence  on 
cryosections of adult rat pancreas. Fig.  1 shows the typical 
Figure 1. Cryosection of adult 
rat  pancreas  stained  with  a 
polyclonal  antibody  against 
SNAP-25.  Nomarski (a)  and 
fluorescence  image (b).  Note 
the  staining of  the  islet  of 
Langerhans and the  absence 
of  fluorescence  in  the  sur- 
rounding exocrine tissue. Bar, 
10 ~m. 
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carboxy-terminal  peptide  of  SNAP-25.  SNAP-25  is  ex- 
pressed in the islet of Langerhans but not in the surrounding 
exocrine tissue. As expected, a cross section of a nerve in the 
same tissue slice was also SNAP-25 positive (not shown). 
Immunofluorescence of SNAP-25 in Primary Islet 
Cells in Culture 
Indirect immunofluorescence studies were performed using 
5-d-old monolayer cultures of primary islet cells from adult 
rat pancreas. As shown in Fig. 2, the staining pattern of a 
monoclonal antibody against SNAP-25 (as well as the poly- 
clonal antibody, not shown) on permeabilized primary islet 
cells in culture also suggests a cell membrane-associated lo- 
calization of SNAP-25. An enrichment of SNAP-25 in an in- 
tracellular, possibly Golgi, region was often visible as ob- 
served previously for PC  12 cells (51). 
Western Blot Analysis of SNAP-2$ in Cells of Different 
Origin and in Different Cellular Fractions 
Western blots were performed using the polyclonal antibody 
against SNAP-25 to examine the presence of SNAP-25 in en- 
docrine and non-endocrine cells. SNAP-25 was strongly ex- 
pressed in primary islet B and non-B ceils (Fig. 3 a, upper 
panel, lanes 3 and 2 respectively), which together build up 
the endocrine pancreas (39). SNAP-25 was also expressed 
in different pancreatic B cell lines, RIN,  (Fig.  3 a, upper 
panel, lane 4) INS-1 (Fig. 3 a, upper panel, lanes 5-7), HIT 
(Figs.  3  b  and 4),  in a  pancreatic non-B cell line (ot-TC, 
glucagon-producing cells [not shown]) and in a pituitary cor- 
ticotroph cell line (AtT-20, Fig. 3 a, upper panel, lane 1). 
The apparent molecular mass of 25 kD corresponds exactly 
to that of SNAP-25 from brain extract (not shown). By con- 
trast SNAP-25 could not be detected in primary pancreatic 
exocrine cells, in a liver cell line (FAO), or COS cells (kid- 
ney) (Fig. 3 a, upperpanel, lanes 8, 9, 10, respectively). Fig. 
3 a,  lower panel,  shows the corresponding actin staining 
used to estimate protein quantity, rather than cell number, 
loaded in each lane. These results show that SNAP-25 ex- 
pression is not confined to the nervous system but is also 
found in the pancreas where it is restricted to endocrine 
cells. 
Analyses of whole cell extracts cannot distinguish between 
soluble and membrane-bound SNAP-25.  Subcellular frac- 
tionation was thus used to this end. The results show that 
SNAP-25 in HIT cells has the biochemical properties of a 
molecule tightly associated with cellular membranes, as has 
been observed for SNAP-25 in neurons (42). In contrast to 
actin which under our assay conditions is found exclusively 
in the cytosol, and the heat shock protein HSP 70 which is 
found mainly in the cytosol and to a lesser extent in the nu- 
clear fraction, SNAP-25 can only be detected in the deter- 
gent soluble fraction of a crude preparation of total cellular 
membranes and not in the nuclear fraction, the cytosol, the 
high salt membrane wash, or the Tritort insoluble membrane 
fraction (Fig. 3 b), 
BoNT/E Cleaves SNAP-25 and Inhibits Insulin 
Release from HIT Cells 
To investigate whether SNAP-25 is involved in exocytosis of 
insulin containing LDCGs we used HIT cells, a pancreatic 
B cell line. HIT cells can be permeabilized with streptoly- 
sin-O to allow exchange of macromolecules (3, 29). Permea- 
bilization is necessary because BoNTs cannot enter primary 
B cells or B cell lines as, in contrast to neurons, these cells 
lack the receptor for the toxins (12, 34). Permeabilized HIT 
cells can still be stimulated to secrete insulin by raising the 
Ca  ++ concentration (22, 29). 
Treatment of permeabilized HIT cells with BoNT/E re- 
suits in cleavage of SNAP-25, visible as a decrease in ap- 
parent molecular mass of •  3 kD, shown in Fig. 4 a, right 
panel. The effect on insulin secretion is shown in Fig. 4 a, 
left panel. At a concentration of 30--40 nM the maximal in- 
hibitory effect of *60%  is reached, which coincides with 
nearly complete cleavage of SNAP,25 (Fig. 4 a). A concen- 
tration of 5-10 nM BoNT/E gives half maximal effects for 
both cleavage of SNAP-25 as well as inhibition of insulin re- 
lease. SNAP-25 is not hydrolyzed when cells are only per- 
meabilized (Fig. 4 a, right  panel) or treated with toxin which 
has been heat inactivated before use (not shown). The heat- 
inactivated toxin also  does not change the  Ca++-response 
(not shown). 
The effect of 40 nM BoNT/E on insulin secretion at vari- 
ous Ca++ concentrations is illustrated in Fig. 5. Whereas in- 
sulin release under low Ca  ++ conditions is not significantly 
altered by the toxin, the inhibitory effect on Ca++-evoked 
release  at  an  intermediate  Ca  ++  concentration  is  almost 
complete.  At  high  Ca++ concentrations  inhibition  was 
around 75 % (this series of experiments has been performed 
with another batch of toxin as compared to Fig. 4 a, where 
maximal inhibition did not exceed 60%). 
Effect of  BoNT/A on SNAP-25 and Insulin Release in 
HIT Cells 
Treatment of  permeabilized HIT cells with BoNT/A resulted 
in a decrease in the apparent molecular mass of SNAP-25 of 
"01 kD (Fig. 4 b, right panel). Maximal cleavage of SNAP- 
25 is obtained at a concentration of 4 nM BoNT/A, which 
is accompanied by a significant decrease in Ca++-stimulated 
insulin release (Fig. 4 b, lefipanel).  Half maximal concen- 
tration for cleavage of SNAP-25 is '~2 nM (Fig. 4 b, right 
panel). As shown in Fig. 4 b, the heat-inactivated toxin does 
not cleave SNAP-25 nor does it influence insulin secretion. 
Once maximal cleavage of SNAP-25 is obtained, inhibition 
of Ca++-evoked release could not be augmented any further 
by raising the toxin concentration up to 64 nM (not shown). 
Although hydrolysis of SNAP-25 by BoNT/A is almost 
complete and very reproducible at all concentrations above 
4 nM, the effect on insulin secretion was highly variable and 
always less efficient than the E type toxin (we therefore did 
not study the effect of BoNT/A at intermediate Ca  ++ con- 
centrations). Inhibition values varied from almost no inhibi- 
tion to a maximum of 45 % between different experiments 
(not shown). Basal release however was never influenced by 
the toxin (not shown). 
Effect of  BoNT/A and BoNT/E in Primary Islet Cells 
To verify that the effects of the toxins, observed in the pan- 
creatic B cell line HIT, are not due to the transformed pheno- 
type  of these  cells,  toxin  treatment  was  performed  on 
streptolysin-O permeabilized primary rat islet cells. As in 
HIT cells cleavage of SNAP-25 was observed after BoNT/E 
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cence staining of  primary islet 
cells  in  culture  using the 
monoclonal antibody against 
SNAP-25. Phase contrast (a) 
and  fluorescence image (b). 
Bar, 10/~m. 
and BoNT/A treatment, resulting in a mobility shift of 3 and 
1 kD, respectively (not shown).  Ca~-induced insulin release 
was inhibited by 60 and 50%, respectively (Fig. 6). 
Discussion 
Pancreatic endocrine cells have several  features in common 
with  neuronal  cells  (18),  including  sensitivity  to  nerve 
growth factor (45) and expression of neuronal proteins such 
as tyrosine hydroxylase (62),  glutamic acid decarboxylase 
(6), and synaptophysin (37, 65). The current scientifc opin- 
ion about the origin of pancreatic endocrine cells, however, 
favors an endodermal lineage rather than development from 
the neuroectoderm (28).  Several types of secretory vesicles, 
Sadoul et al. SNAP-25 and Insulin Release  1023 Figure  3.  Detection  of  SNAP-25  in 
different cells and different cellular frac- 
tions.  (a)  Western  blot  of lysates  of 
different primary ceils or cell lines, in- 
cubated  with  the  polyclonal  antibody 
against  SNAP-25 (upper panel)  or  a 
polyclonal antibody against actin (lower 
panel).  (Lane  1)  1.5  x  105  AtT-20 
cells;  (lane  2)  4  ×  ltY  primary islet 
non-B cells;  (lane 3) 4  x  105 primary 
islet B cells;  (lane  4)  1.5  ×  105 RIN 
cells;  (lanes 5-7)  1.5, 4, and 10  ×  1@ 
INS-1 cells, respectively;  (lane 8) 4  × 
1@  exocrine  cells;  (lane  9)  4  ×  1@ 
FAO  cells;  (lane  10)  4  x  105  COS 
cells. The primary islet cells were first 
sorted  by  autofluorescence-activated 
flow cytometry to obtain populations of 
B and non-B cells. (b) Western blot of 
different  cellular  fractions  from  HIT 
cells (10 t~l/lane, corresponding to frac- 
tions  obtained  from  105  cells)  incu- 
bated  with  the  monoclonal  antibody 
against SNAP-25, a polyclonal antibody 
against  actin  and  a  monoclonai  anti- 
body against the heat shock protein HSP 
70. (Lane 1) Nuclear fraction;  (lane 2) 
postnuclear  supernatant;  (lane 3) cyto- 
sol; (lane 4) high salt membrane wash; 
(lane 5) Triton X-100 soluble membrane 
fraction; (lane 6) Triton X-100 insoluble 
membrane fraction. 
different in terms of biogenesis, membrane composition, and 
secretory pathway, have been described both in neurons and 
endocrine cells. In addition to SSVs, used to store classical 
neurotransmitters  including  7-arnino  butyric acid,  glycine 
and acetylcholine, neurons, and neurosecretory cells (pheo- 
chromocytoma, adrenal chromaflin ceils) also contain large 
dense core vesicles (LDCV) to store peptide neurotransmit- 
ters such as vasopressin and substance P  (18).  Insulin-con- 
taining  LDCGs of pancreatic B  cells resemble LDCVs of 
neurons. B cells contain also a second population of vesicles 
which  resemble  SSVs.  These  synaptic-like  microvesicles 
(SLMV) contain 7-amino butyric acid (49). The membranes 
of LDCVs and SSVs differ in their protein composition (36). 
In addition, the molecular process of exocytosis of LDCVs 
and SSVs can be distinguished in frog motor neurons using 
ot-latrotoxin.  This  toxin  leads  to  a  massive exocytosis of 
SSVs whereas the number of LDCVs in the same nerve end- 
ing is not reduced (30).  Similarities and differences of neu- 
rons vs endocrine cells and their different types of secretory 
vesicles raise the question whether regulated secretion in the 
two cellular systems follows the same molecular principles. 
We thus wanted to address the question whether the mecha- 
nism for insulin secretion from LDCGs resembles transmit- 
ter secretion from SSVs. 
In the present study SNAP-25, known as a neuron specific 
protein (15, 21, 42, 43) involved in axonal elongation (41) and 
fusion of synaptc vesicles with the presynaptic membrane 
(13, 58), has been shown to be expressed in pancreatic endo- 
crine cells. As in neurons (42) SNAP-25 is found in the de- 
tergent soluble fraction of a crude preparation of total cellu- 
lar membranes from the insulinoma cell line HIT. SNAP-25 
was however not detectable in cell lines such as FAO (hepa- 
toma) or COS (kidney), which secrete proteins only by the 
constitutive pathway. Strikingly, SNAP-25 is also absent from 
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for  treatraent  of  streptoly- 
sin-O  permeabilized  HIT cells 
with BoNT/E (a) or BoNT/A 
(b).  Left  panels  show  the 
effect  of toxin treatment on 
Ca++-induced insulin release 
(10/~M free  Ca  ++) (mean + 
SD, n =  3). Dashed line indi- 
cates  insulin  release  under 
low  Ca++ condition (0.1 #M 
free Ca++), which was not al- 
tered  by  the  toxin.  Right 
panels  show  corresponding 
Western blots of cell lysates 
using  the  monoclonal  anti- 
body  against  SNAP-25  to 
evaluate effect of toxin treat- 
ment on SNAP-25, 
Figure 5.  Effect of 40 nM BoNT/E on insulin secretion from per- 
meabilized HIT cells at various free  Ca++ concentrations (esti- 
mated using a  Ca  ++ concentration curve measured with  a  Ca  ++ 
electrode).  Mean + SD; n = 6 from two independent  experiments. 
Figure 6. Effect of  40 nM BoNT/A and BoNT/E on insulin  secretion 
from streptolysin-O permeabilized  primary rat islet cells under low 
(0.1 #M free Ca  ++) and high (10/zM  free Ca  ++) Ca  ++ conditions. 
Mean q- SD, n  ~- 3. 
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gerhans and possess a regulated secretory pathway for secre- 
tion from zymogen-containing granules (1). 
By analogy to neurons, SNAP-25  in pancreatic B cells 
could be involved in secretion of v-amino butyric acid from 
SLMVs  rather  than  in  exocytosis  of  insulin-containing 
LDCGs. The observation that release of vasopressin, a pep- 
tide  neurotransmitter,  stored  in  LDCVs,  is  inhibited  by 
BoNT/A in isolated neurosecretory nerve terminals, makes 
an involvement of SNAP-25  in exocytosis of LDCGs, how- 
ever, likely (17). We therefore used the neurotoxins BoNT/A 
and BoNT/E as tools to evaluate the role of SNAP-25  in 
secretion of insulin from LDCGs. Using permeabilized HIT 
ceils and primary rat islet cells we have shown that, as in 
neuronal ceils, SNAP-25  is hydrolyzed by these two toxins. 
The molecular weight shift and the fact that the polyclonal 
antibody directed against the  12  carboxy-terminal amino 
acids of SNAP-25  does not recognize the cleaved products 
(not shown) suggests that cleavage occurred at the expected 
sites, 9 and 26 residues from the carboxy terminus, respec- 
tively (10, 55). 
Cleavage of SNAP-25 by BoNT/A and BoNT/E resulted in 
inhibition of Ca++-induced insulin release in HIT cells as 
well as in primary islet cells. The inhibition of BoNT/A var- 
ied from experiment to experiment and was generally less 
pronounced than that of BoNT/E. Insulin release under low 
Ca  ++ conditions was not affected by either toxin. 
Neither toxin treatment resulted in complete inhibition of 
Ca++-induced insulin secretion, although both toxins were 
able  to  hydrolyze SNAP-25  almost quantitatively.  Note, 
however,  that  for both  toxins  a  faint band  of uncleaved 
SNAP-25  was always visible even when high toxin concen- 
trations were used. It is not clear whether this is due to in- 
complete permeabilization, too short a treatment with toxin, 
or  whether there  is  a  small  pool  of SNAP-25  protected 
against cleavage as proposed by Niemann et al. (38).  In fact 
a recent study by Hayashi et al. (24) has shown that BoNT/A 
and E have little effect on SNAP-25  when SNAP-25  is as- 
sociated with VAMP and syntaxin in a complex assembled 
in vitro using the recombinant proteins. Thus similar com- 
plexes possibly present in the cell might protect small quanti- 
fies of SNAP-25  from being cleaved by the toxins. The fact 
that almost complete cleavage  of SNAP-25  results in only 
partial inhibition of insulin release is intriguing but has some 
precedents. It has been shown for instance that tetanus toxin, 
which can hydrolyze cellubrevin, inhibits only 35 % of exo- 
cytosis of transferrin receptor containing vesicles, although 
cellubrevin is completely digested under the assay conditions 
(19). More important for our observations, however, is that 
several  studies  show  only  a  partial  inhibitory  effect of 
BoNT/A on neurotransmitter release (45-60%),  especially 
when  permeabilized  cells  are  used  (2,  17,  31,  59,  60). 
BoNT/E has been used in only a few assay systems where 
it is usually more effective than the A type toxin (7, 11). As 
the  proteolytic target  of BoNT/A  and  BoNT/E  was  not 
known at the time of these previous studies, this is the first 
comparative study on inhibition of secretion with respect to 
cleavage of SNAP-25. 
The only partial inhibition of insulin release caused by 
BoNT/A and BoNT/E could have several explanations. It is 
possible that even a very small number of uncleaved SNAP- 
25 molecules is sufficient to allow a substantial amount of 
fusion of insulin-containing granules to occur. It is also pos- 
sible that another functionally equivalent molecule, not at- 
tacked by the toxin, can still function to give rise to part of 
the  Ca  ++  response.  Alternatively,  BoNT/A  and  BoNT/E 
may attack additional proteins  which are not completely 
cleaved under these conditions but which are implicated in 
insulin secretion. Recently it has been shown that BoNT/E 
hydrolyses denatured actin in vitro at several sites all charac- 
terized by Arg or Lys before the cleavage point (16). SNAP- 
25 is also cleaved after an arginine residue, between Argl80 
and Ilel81, but as there are other Arg-Ile peptide bonds in 
SNAP-25 which are not hydrolyzed by BoNT/E, the tertiary 
structure of the substrate must be essential for the action of 
the toxin (56).  In any event, incubation of the Western blot 
with a polyclonal antibody against actin did not show any 
actin degradation products (not shown).  There is another 
report suggesting that BoNT/A might cleave additional pro- 
teins besides SNAP-25. Steinhardt et al. showed that reseal- 
ing of fibroblast plasma membranes by a vesicular mecha- 
nism is inhibited by BoNT/A (61). As fibroblasts do not 
express SNAP-25,  inhibition could be due to cleavage of an 
isoform of SNAP-25 so far not detected with the available an- 
tibodies, or to cleavage of an unrelated protein. 
An additional explanation for the partial inhibitory effect 
of the BoNTs could be that a number of insulin-containing 
granules are already docked at the plasma membrane, or 
primed to fuse, and therefore do not require SNAP-25  for 
subsequent fusion. The fact that basal insulin release is not 
influenced by the toxin supports this view, as such release 
might be due to occasional fusion of already docked gran- 
ules. SNAP-25  would therefore be responsible for the first 
docking step of the insulin-containing granule to the plasma 
membrane (57). This would be in agreement with the model 
proposed by StUner et al., which suggests that the first step 
in exocytosis is the docking of the secretory vesicle by bind- 
ing of the integral vesicle protein synaptobrevin to its recep- 
tors, syntaxin and SNAP-25,  in the plasma membrane. 
The inhibitory effect of BoNT/E is somewhat more pro- 
nounced at intermediate Ca  ++ concentrations. In neurons it 
has been shown that a rise in intracellular Ca  ++, induced by 
amino  pyridines  or  Ca++-ionophores,  can  counteract the 
poisoning effect of BoNT/A and E but not of BoNT/B, D, and 
F (5, 20, 32, 33). It may be that only the "calcium-SNAP-25" 
conformation is active in the secretion process and that the 
percent of  molecules able to reach this conformation is lower 
when 9  amino acids at the carboxy terminus are missing 
(cleavage by BoNT/A) and yet lower when 26 amino acids 
are missing (cleavage  by BoNT/E).  High Ca  ++ concentra- 
tions used as stimulus for insulin secretion could push the 
equilibrium to the calcium conformation and thus shadow 
the toxin effect. This could also explain why treatment with 
BoNT/A in such a sensitive assay system was highly variable 
in terms of inhibition of insulin release and generally less 
effective than BoNT/E treatment. Recent in vitro studies on 
the binding properties of recombinant SNAP-25, VAMP, and 
syntaxin also support the notion that treatment with BoNT/E 
and more obviously with BoNT/A may result in only partial 
inhibition of exocytosis. It has been shown that SNAP-25, 
VAMP, and syntaxin assemble into a high affinity complex 
(44) resistant to SDS (24).  SNAP-25 cleaved by BoNT/A or 
E can still associate with VAMP and syntaxin to form a high 
affinity complex.  SDS  resistance  of this  complex,  how- 
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BoNT/A or E treated  SNAP-25  is used, respectively (24). 
Thus SNAP-25 lacking the last carboxy terminal amino acids 
might still be able to fulfill most of its role in the docking 
and/or fusion process although  not as efficiently as intact 
SNAP-25. This might lead to the observation of a partial in- 
hibition of exocytosis after BoNT/A and E treatment. 
In conclusion our results demonstrate that SNAP-25 is ex- 
pressed in pancreatic endocrine cells. Cleavage of SNAP-25 
by  BoNT/A  and  BoNT/E  results  in  partial  inhibition  of 
Ca++-dependent  insulin  release  which  suggests  a  role  for 
SNAP-25  in exocytosis of endocrine LDCGs. 
We thank St6phane Dupuis for excellent technical assistance. We also thank 
D. Nappey for preparing the HIT cell cultures, D. Wohlwend for technical 
advice in fluorescence-aetival~d cell sorting, and Dr. Gabbiani for the anti- 
actin antibody. 
This work was supported by the National Institutes of Health grant no. 
DK 35292  to P. A. Halban, the Swiss National Science  foundation grant 
nos. 31-40839.94  to P. A. Halban and 32.32376.91  to C, B. Wollheim and 
a  fellowship  from  the  Juvenile  Diabetes  Foundation  International  no. 
393936 to K.  Sadoul. 
Received  for publication 30 May  1994 and in revised form 23 November 
1994. 
Reflfrence$ 
1. Almert-Hilger, G., and B. Wiedenmann. 1992. The amphicrine pancreatic 
cell line, AR 42 J, secretes GABA and amylase by separate regulated 
pathways. FEBS (Fed. Fur. Biochem.  Soc.) Lett.  314:41--44. 
2. Ahnert-Hilger, G., and U. Weller. 1993.  Comparison of the intracellular 
effects of clostridial neurotoxins on exocytosis from streptolysin O-per- 
meabflized rat pheochromocytoma  (PC 12) and bovine adrenal chromaffin 
cells. Neuroscience.  53:547-552. 
3. Ahnert-Hilger, G., M. F. Bader, S. Bhakdi, andM. Grntzl. 1989. Introduc- 
tion of macromolecules into bovine adrenal medullary chromalfin cells 
and rat pheochromocytoma ceils (PC 12) by parmeabilization with strep- 
tolysin O: inhibitory effect of tetanus toxin on catecholamine secretion. 
J. Neurochem. 52:1751-1758. 
4. Asfari, M., D. Janjic, P. Meda, G. Li, P. A. Halban, and C. B. Wollheim. 
1992,  Establishment of 2-mereaptcethanoi-dependent differentiated  in- 
sulin-secreting cell lines. Endocrinology.  130:167-178. 
5. Ashton, A. C., and J. O. Doily. 1991. Microtobule-dissociating drugs and 
A23187 reveal differrences in the inhibition of synaptosomal transmitter 
release  by  botulinum  neurotoxins  types  A  and  B.  3".  Neurochem. 
56:827-835. 
6. Baekkeskov, S., H. J. Aanstoot, S. Christgan, A. Reetz, M. Solimena, M. 
Cascalho  F.  FOlIi, H.  Richter-Olesen,  and  P.  De  Camilli.  1990. 
Identification  of the 64K autoantigen in insulin-dependent  diabetes as the 
GABA-synthesizing  enzyme glutamic acid decarboxylase (published er- 
ratum appears inNature (Lond.).  1990. Oct 25; 347(6295):782).  Nature 
(Lond.).  347:151-156. 
7. Banerjee, A., T. F. J. Martin, and B. R. DasGupta. 1993.  Nerve growth 
factor induces sensitivity to botolinum neurotoxin type A in norepineph- 
rine-socreting PC 12 cells. Neurosei. Lett.  164:93-96. 
8.  Baumert, M., P. R. Maycox, F. Navone, P. De Camilli, and R. Jahn. 1989. 
Synaptobrevin: an integral membrane protein of 18,000 daltons present 
in small synaptic vesicles of rat brain. EMBO (Eur. Mol.  Biol.  Organ.) 
J.  8:379-384. 
9. Bennett, M. K., N. Calakos, and R. H. Scheller.  1992. Syntax.in: a synaptic 
protein  implicated in the docking of synaptic vesicles at presynaptic 
zones. Science (Wash.  DC). 257:258-259. 
10. Binz, T., J. Blasi, S. Yamasaki, A. Baumeister, E. Link, T. C. Siidbof, 
R. Jahn, and H. Niemann. 1994. Proteolysis of SNAP-25 by types E and 
A botulinal neurotoxins. J. Biol.  Chem.  269:1617-1620. 
11. Bitnter, M. A., B. R. DasCmpta,  and R. W.  Holz.  1989.  Isolated light 
chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin- 
permeabilized chromaflin cells. J. Biol.  Chem.  264:10354-10360. 
12. Black, J. D., and J. O. Dolly. 1987. Selective location of accoptors for botu- 
linum neurotoxin A in the central and peripheral nervous systems.  Neuro- 
science.  23:767-779. 
13. Blasi, J., E. R. Chapman, E. Link, T. Binz, S. Yamasaki, P. De Camilli, 
T. C. Sfidhof,  H. Niemann, and R. Jahn.  1993.  Bontlinum neurotoxin 
A  selectively cleaves the synnptic protein SNAP-25.  Nature  (Lond.). 
365:160-163. 
14. Blasi, J., E. R. Chapman, S. Yamasaki, T. Binz, H. Niemann, and R. Jahn. 
1993. Botolinum  neurotoxin C 1 blocks neurotransmitter  release by means 
of cleaving HPC-l/syntaxin. EMBO  (Eur.  Mol.  Biol.  Organ.) J.  12: 
4821--4828. 
15. Catsicas, S., D. Larhammar, A. Blomqvist, P. P. Sanna, R. J. Milner, and 
M. C. Wilson. 1991. Expression of a conserved cell-type-specific  protein 
in nerve terminals coincides with synaptogenesis. Proc. Natl. Acad.  Sci. 
USA. 88:785-789. 
16. DasGupta, B. R., and W. Tepp. 1993. Protease activity of botulinnm neu- 
rotoxin type E and its light chain: cleavage of actin. Biochem.  Biophys. 
Res.  Commun.  190:470--474. 
17. Dayanithi, G.,  G.  Ahnert-Hilger, U. Weller, J.  J.  Nordmann, and M. 
Gratzl.  1990.  Release of vasopressin from isolated permeabilized neu- 
rosecretory nerve terminals is blocked by the light chain of botulinum A 
toxin. Neuroscience.  39:711-715. 
18. De Camilli, P., and R. Jahn. 1990. Pathways to regulated exocytosis  in neu- 
rons. Annu.  Rev.  Physiol.  52:625-645. 
19. Galli,  T.,  T.  Chilcote, O.  Mundigl, T.  Binz, H.  Niemann, and P.  De 
Carnilli.  1994.  Tetanus toxin-mediated cleavage of ceUubrevin impairs 
exocytosis of transferrin receptor-containing vesicles in CHO cells. J. 
Cell Biol.  125:1015-1024. 
20. Gansel, M., R. Penner and F. Dreyer. 1987. Distinct sites of action ofclos- 
tridial  neurotoxins revealed by double-poisoning of mouse motor nerve 
terminals. Pflugers Arch.  409:533-539. 
21, Geddes, J. W., E. J. Hess, R. A. Hart, J. P. Kesslak, C. W. Cotman, and 
M. C. Wilson. 1990.  Lesions of hippoeampal circuitry define synnpto- 
somal-associated protein-25 (SNAP-25) as a novel presynaptic marker. 
Neuroscience.  38:515-525. 
22. Gomperts, B. D., and P. E. Tatham. 1992. Regulated exocytotic secretion 
from permeabilized cells. Methods Enzymol.  219:178-189. 
23. Halban, P. A. 1990, Proinsulin trafficking and processing in the pancreatic 
B cell. Trends Endocrinol.  Metab.  1:261-265. 
24. Hayashi, T., H. McMabon, S. Yamasaki, T. Binz, Y. Hata, T. C. Siidhof, 
and H. Niemann. 1994. Synaptic vesicle membrane fusion complex: ac- 
tion of clostridal neurotoxins on assembly. EMBO (Fur. Mol.  Biol.  Or- 
gan.) J.  13:5051-5061. 
25. Herbert, V., K.-S. Lau, C, W. Gottlieb, and S. J. Bleicher.  1965. Coated 
charcoal immunoassay  of insulin. J. Clin. Endocrinol.  Metab.  25:1375- 
1384. 
26. Hess, D. T., T. M. Slater,  M. C. Wilson, and J. H. P. Skene. 1992. The 
25 kDa synaptosomal-associated  protein SNAP-25 is the,major methio- 
nine-rich polypeptide  in rapid axonal transport and a major substrate for 
palmitoylation in adult CNS. J. Neurosci.  12:4634--4641. 
27. Laemmii, U. K. 1970. Cleavage of structural proteins during the assembly 
of the head of the bacteriophage T4. Nature (Lond.).  227:680-685. 
28. Le Douarin, N. M. 1988. On the origin of pancreatic endocrine cells. Cell. 
53:169-171. 
29. Li, G., G. Hidaka, and C. B. Wullheim. 1992. Inhibition of voltage-gated 
Ca  2÷ channels and insulin secretion in HIT cells by the Ca2+/calmodulin - 
dependent protein kinase II inhibitor KN-62: comparison with antagonists 
of calmodulin and L-type Ca  2+ channels. Mol. Pharmacol.  42:489-498. 
30. Matteoli, M., C. Haimann, F. Torri-Tarelli, J. M. Polak, B. Cecearelli, 
and P. De Camilli. 1988. Differential effect of ot-latrotoxin on exocytosis 
from small synaptic vesicles and from large dense-core vesicles contain- 
ing calcitonin gene-related peptide at the frog neuromuscular junction. 
Proc.  Natl.  Acad.  Sci.  USA.  85:7366-7370. 
31. Mclnnes, C., and J. O. Dolly. 1990. Ca2(+)-dependent noradrenaline re- 
lease from permeabilised PC 12 cells is blocked by bomlinnm neurotoxin 
A or its Dight  chain. FEBS (Fed. Fur. Biochem.  Soc.) Lett.  261:323-326. 
32. Molgo, J., J. X. Cornelia, P. D. Angant, D. M. Pecot, N. Tabti, L. Faille, 
A. Mallart, and S. Thesleff. 1990. Presynaptic actions of botulinai neu- 
rotoxins at vertebrate neuromuscular junctions. J.  Physiol.  Paris.  84: 
152-166. 
33. Molgo, J., B. R. DasGupta, and S, Thesleff. 1989. Characterization of the 
actions of botolinnm neurotoxin type E at the rat neuromuscular  junction. 
Acta Physiol.  Scand.  137:497-501. 
34. Montecueeo, C. 1986. How do tetanus and botulinnm toxins bind to neu- 
ronal membranes? Trends Biochem.  Sci.  11:314-317. 
35. Montecucoo, C., and G. Schiavo. 1993. Tetanus and botulism neurotoxins: 
a new group of zinc proteases. Trends Biochem.  Sci.  18:324-327. 
36. Navone, F., G. Di Gioia, R. Jahn, M. Browning, P. Greengurd, and P. 
De Camilli. 1989. Microvesieles of the neurohypophysis are biocbemi- 
cally related to small synaptic vesicles of presynaptic nerve terminals. J. 
Cell Biol.  109:3425-3433. 
37. Navone, F., R. Jahn, G. Di Gioia, H. Stukenhrok, P. Greengard and P. 
De Camilli. 1986. Portein p38: an integral membrane protein specific for 
small vesicles of neurons and neuroendocrine ceils. J.  Cell Biol.  103: 
2511-2527. 
38. Niemann, H., J. Blasi, and R. Jahn.  1994.  Clostridial neurotoxins: new 
tools for dissecting exocytosis. Trends  Cell Biol.  4:179-185. 
39. Orci, L. 1982, Macro and micro-domains  in the endocrine pancreas. Diabe- 
tes.  31:538-565. 
40. Orci, L. 1985. The insulin factory: a tour of the plant surroundings and a 
visit to the assembly line.  Diabetologia.  28:528-546. 
41. Oseu-Sand, A., M.  Catsicas, J.  K.  Staple,  K.  A. Jones, G.  Ayala, J. 
Knowles, G. Grenningloh and S. Catsicas.  1993.  Inhibition of axnnal 
growth by SNAP-25 antisense oligonuclootides  in vitro and in vivo. Na- 
Sadoul  et al. SNAP-25 and Insulin  Release  1027 ture (Land.).  364:445--448. 
42. Oyler, G. A., G. A. Higgins, R. A. Hart, E. Battenberg, M. Billingsley, 
P.  E. Bloom, and M.  C. Wilson. 1989.  The identification  of a novel 
synaptosomal-asseciated  protein, SNAP-25, differentially  expressed by 
neuronal subpopolations. Y.  Cell Biol.  109:3039-3052. 
43. Oyler, G. A., J. W. Poili, G. A. Higgins, M. C. Wilson, and M. L. Bil- 
lingsley. 1992.  Distribution and expression of SNAP-25 immunoreac- 
tivity in rat brain, rat PC-12 cells and human SMS-KCNR neuroblastoma 
cells. Dev. Brain Res. 65:133-146. 
44. Pevsner, J., S.-C. Hsu, J. E. A. Braun, N. Calakos, A. E. Ting, M. K. 
Bennett, and R. H. Scheller. 1994. Specificity and regulation ofa synaptic 
vesicle docking complex. Neuron. 13:353-361. 
45. Polak, M., R.  Scharfmann, B.  Seilheimer, G. Eisenharth, D.  Dressier, 
I. M. Verma, and H. Potter. 1993. Nerve growth factor induces neuron- 
like differentiation  of an insulin-secreting  pancreatic beta cell line. Proc. 
Natl. Acad.  Sci.  USA. 90:5781-5785. 
46. Praz, G. A., P. A. Halban, C. B. Wollheim, B. Blondel, A. J. Strauss, and 
A. E. Renold. 1983. Regulation of immunorenctive-insulin  release from 
a rat cell line (RINmSF).  Biochem. Y. 210:345-352. 
47. Prentki, M., D. Janjic, and C. B. Wollheim. 1983. The regulation ofex- 
tramitocbondrial steady state free Ca  2+ concentration by rat insulinoma 
mitochondria. J. Biol.  Chem.  258:7597-7602. 
48. Prentki, M., and F. M. Matschinsky. 1987.  Ca  2+, cAMP, and pbospho- 
lipid-derived messengers in coupling mechanisms of insulin secretion. 
Physiol.  Bey. 67:1185-1248. 
49. Rectz,  A.,  M.  Solimena, M.  Matteoli,  F.  Folli,  K. Takei, and P.  De 
Camilli.  1991.  GABA and pancreatic beta-cells:  colocalization  of glu- 
tamic acid decarboxylase (GAD) and GABA with synaptic-like micro- 
vesicles suggests  their role in GABA storage and secretion. EMBO (Fur. 
biol. Biol.  Organ.)J.  10:1275-1284. 
50. Rouiller, D. G., V. Cirulli, and P. A. Halban. 1990. Differences in aggre- 
gation properties and levels of  the neural cell adhesion molecule (NCAM) 
between islet cell types. Exp.  Cell Res.  191:305-312. 
51. Sanna, P, P., F. E. Bloom, and M. C. Wilson. 1991. Dibotyryl-cAMP in- 
duces SNAP-25 transiocation into the neurites in PC12. Dev. Brain Res. 
59:104-108. 
52. Schlavo,  G.,  F.  Benfenati,  B.  Poulain,  O.  Rossetto, P.  Polverino de 
Lanreto,  B.  R.  DasGupta,  and  C.  Montecucco.  1992.  Tetanus and 
botulinum-B neurotoxins block neurotransmitter release by proteolytic 
cleavage of synaptobrevin. Nature (Lond.).  359:832-835. 
53. Schiavo, G., O. Rossetto, S. Catsicas, P. Polverino de Lanreto, B. R. Das- 
Gupta,  F.  Benfenati, and C.  Montecucco.  1993.  Identification  of the 
nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. 
J.  Biol.  Chem.  268:23784-23787. 
54. Schiavo, G., O. Rossetto, A.  Santucci, B.  R.  DasGupta, and C. Mon- 
tecucco. 1992. Botulinum neurotoxins are zinc proteins. J. Biol.  Chem. 
267:23479-23483. 
55. Schiavo, G., A. Santucci, B. R. DasGupta, P. P. Mehta, J. Jontes, F. Ben- 
fenati, M. C. Wilson, and C. Montecocco. 1993. Botulinum  neurotoxins 
serotypes A and E cleave SNAP-25 at distinct COOH-terminal paptide 
bonds. FEBS (Fed. Fur. Biochem.  Soc.) Lett.  335:99-103. 
56. Schlavo, G., C. C. Shone, O. Rossetto, F. C. Alexander, and C. Mon- 
tecucco. 1993. Botulinum neurotoxin serotype F is a zinc endopeptidase 
specific  for VAMP/syrmptobrevin. J.  Biol.  Chem.  268:11516-11519. 
57. S611ner, T., M. K. Bennett, S. W. Whitebeart, R. H. ScbeUer, and J. E. 
Rothman. 1993.  A protein assembly-disassembly  pathway in vitro that 
may correspond to sequential steps of synaptic vesicle docking, activa- 
tion, and fusion. Cell.  75:409--418. 
58. S611ner, T., S. W. Whiteheart, M. Brenner, H. Erdjument-Bromage, S. 
Geromanos, P. Tempst, and J. E. Rothman. 1993. SNAP receptors impli- 
cated in vesicle targeting and fusion. Nature (Land.).  362:318-324. 
59. Stecher, B., M. Gratzl, and G. Ahnert-Hilger. 1989. Reductive chain sepa- 
ration of  botulinum  A toxin- a prerequisite to its inhibitory action on exo- 
cytosis  in  chromaffin cells.  FEBS  (Fed.  Fur.  Biochem.  Soc.)  Len. 
248:23-27. 
60. Stecher, B., U. Weller, E. Habermann, M. Gratzl, and G. Almert-Hilger. 
1989.  The light chain but not the heavy chain of botulinum A toxin in- 
hibits exocytosis from pcrmeabilized adrenal chromaflin cells.  FEBS 
(Fed. Fur. Biochem.  Soc.) Lett.  255:391-394. 
61. Steinhardi, R. A., (3. Bi, and J. M. Alderton. 1994. Cell membrane reseal- 
ing by a vesicular mechanism  similar to neurotransmitter  release. Science 
(Wash.  DC). 263:390-393. 
62. Teitelman, G., and J. K. Lee. 1987. Cell lineage analysis of pancreatic islet 
cell development: glucagon and insulin cells arise from catecholaminer- 
gic precursors present in the pancreatic duct. Dev.  Biol.  121:454-466. 
63. Towbin, H., T. Staehelin,  and J. Gordon.  1979.  Electrophoretic  transfer 
of proteins from polyacrylamide gels to nitrocellulose sheets: procedure 
and some applications. Proc. Natl. Acad. Sci.  USA. 76:4350-4354. 
64. Trimble, W. S., D. M. Cowan, and R. H. Scheller.  1988. Vamp-1: a synap- 
tic vesicle-associated integral membrane protein. Proc. Natl. Acad.  Sci. 
USA. 85:4538-4542. 
65. Wiedenmann, B., W. W. Franke, C. Kulen, R. Moll, and V. E. Gould. 
1986. Synaptophysin: a marker for nenroendocrine cells and neoplasms. 
Proc. Natl.  Acad.  Sci.  USA.  83:3500-3504. 
The Journal of Cell Biology, Volume 128,  1995  1028 